← Back to Clinical Trials
Recruiting NCT05094115

NCT05094115 Enhancing Resiliency and Optimizing Readiness in Military Personnel

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05094115
Status Recruiting
Phase
Sponsor The University of Texas Health Science Center at San Antonio
Condition Resilience, Psychological
Study Type INTERVENTIONAL
Enrollment 600 participants
Start Date 2021-10-04
Primary Completion 2026-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Psychological Flexibility Training (PFT)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 600 participants in total. It began in 2021-10-04 with a primary completion date of 2026-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Security Force Assistance Brigades (SFABs) are specialized United States Army units formed to train, advise, assist, enable and accompany operations with allied and partner nations. Security Force Assistance Brigades are composed of roughly 800 senior military personnel, primarily commissioned and non-commissioned officers selected from regular Army units across a wide range of military specialties. Because of the high operational tempo (OPTEMPO) of these units, individual resiliency is of utmost importance in maintaining readiness to successfully execute critical, high-stress missions. Acceptance and Commitment Training (ACT) is an evidence-based intervention with strong potential to enhance resiliency by bolstering psychological flexibility along with other factors which have been demonstrated to optimize individual and group performance. This project will compare an Acceptance and Commitment Training-based resiliency-enhancement training program as compared to training as usual in 600 3rd Security Force Assistance Brigades soldiers stationed at Fort Hood in Killeen, Texas. Assessment measures related to resilience will be administered before and after training as well as before and after deployment. Assessments will be conducted at baseline, and every 4 months thereafter for a total of 16-months.

Eligibility Criteria

Inclusion Criteria: * Adult 18 or older * Male or female soldiers assigned to the 3rd SFAB Exclusion Criteria: * None

Contact & Investigator

Central Contact

Alan Peterson, PhD

✉ petersona3@uthscsa.edu

📞 210-562-6700

Principal Investigator

Alan Peterson, PhD

PRINCIPAL INVESTIGATOR

University of Texas Health San Antonio

Frequently Asked Questions

Who can join the NCT05094115 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Resilience, Psychological. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05094115 currently recruiting?

Yes, NCT05094115 is actively recruiting participants. Contact the research team at petersona3@uthscsa.edu for enrollment information.

Where is the NCT05094115 trial being conducted?

This trial is being conducted at Killeen, United States.

Who is sponsoring the NCT05094115 clinical trial?

NCT05094115 is sponsored by The University of Texas Health Science Center at San Antonio. The principal investigator is Alan Peterson, PhD at University of Texas Health San Antonio. The trial plans to enroll 600 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology